Health ❯ Obesity ❯ Weight Management

Medications

GLP-1 Drugs GLP-1 Receptor Agonists Tirzepatide Ozempic Semaglutide GLP-1 Agonists Oral Treatments FDA Approval Orforglipron Insurance Coverage GLP-1 Therapy Semaglutide Benefits Patient Access Long-term Effects Effects of Weight Loss Medications Anti-Obesity Drugs Eli Lilly Weight Loss Medications GLP-1 Zepbound Delivery Services GLP-1 RAs Clinical Trials

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

The warning focuses on mass-marketed 'personalized' versions sold outside FDA review.

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

Pilot Study Ties GLP-1 Drugs to Slower Alcohol Absorption and Milder Intoxication

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials